Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Phibro Animal Health Corporation - Class A Common Stock (NQ:PAHC)

20.22 -1.68 (-7.67%)
Streaming Delayed Price Updated: 1:22 PM EDT, Apr 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Phibro Animal Health Corporation - Class A Common Stock

< Previous 1 2 Next >
Novartis Earns Near-Best Overall Rating As Profit Growth Climbs
Novartis ranks No. 1 among in the 33-stock Medical-Ethical Drugs industry group. Novartis got a Composite Rating upgrade to 96 on Wednesday. 
Via Investor's Business Daily
Novartis Earnings Surprised The Street; Still Going Strong Despite Market Correction
Highly ranked Novartis is forming the right side of a long cup base with a buy point of 120.92. And it's literally running higher. 
Via Investor's Business Daily
Earnings Scheduled For February 5, 2025
Via Benzinga
Limoneira And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Bristol Myers Squibb Stock Earns 83 RS Rating
On Thursday, Bristol Myers Squibb stock got a positive adjustment to its Relative Strength (RS) Rating, from 80 to 83. 
Via Investor's Business Daily
What's Next: Phibro Animal Health's Earnings Preview
Via Benzinga
Recap: Phibro Animal Health Q2 Earnings
Via Benzinga
Earnings Scheduled For February 7, 2024
Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million. 
Via Benzinga
Phibro Animal Health's Ex-Dividend Date Is Tuesday, Here's What You Need To Know
Via Benzinga
What 4 Analyst Ratings Have To Say About Phibro Animal Health
Via Benzinga
Bristol Myers Squibb Stock Gets Relative Strength Rating Upgrade
On Friday, Bristol Myers Squibb stock earned an upgrade to its Relative Strength (RS) Rating, from 62 to 79. 
Via Investor's Business Daily
Rivian Automotive Cuts Production Outlook, Joins EVgo And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Bristol-Myers Squibb's Profits, Stock Price Kick Into High Gear
A Relative Strength Rating upgrade for Bristol Myers Squibb shows improving technical performance. Will it continue? 
Via Investor's Business Daily
Executives Buying BJ's Restaurants And 2 Other Stocks
Via Benzinga
How To Invest In Small Cap Value Stocks In 2024
Many of the small caps have gotten cheap. If you want to find value stocks, the small caps is the place to look. 
Via Talk Markets
PAHC Stock Earnings: Phibro Animal Health Beats EPS, Beats Revenue for Q3 2024
PAHC stock results show that Phibro Animal Health beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024. 
Via InvestorPlace
Where Phibro Animal Health Stands With Analysts
Via Benzinga
Earnings Outlook For Phibro Animal Health
Via Benzinga
Recap: Phibro Animal Health Q3 Earnings
Via Benzinga
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
Via Benzinga
Phibro Animal Health's Return On Capital Employed Overview
Via Benzinga
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results. 
Via Benzinga
Why Shares of Phibro Animal Health Are Dropping This Week
The company's shares have been slipping since it announced fiscal 2023 fourth-quarter earnings. 
Via The Motley Fool
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Earnings Scheduled For August 30, 2023
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its second quarter. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 89 companies set new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 21, 2022
Via Benzinga
Phibro Animal Health's Return On Capital Employed Insights
Pulled from Benzinga Pro data, Phibro Animal Health (NASDAQ:PAHC) showed a loss in earnings since Q3, totaling $7.49 million. Sales, on the other hand, increased by 6.55% to $255.30 million during Q4. 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.